Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Kumar, Mukesh ^a   Roe, Kelsey ^a   Nerurkar, Pratibha V ^a   Orillo, Beverly ^a   Thompson, Karen S ^a   Verma, Saguna ^a   Nerurkar, Vivek R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cell adhesion molecules; Neuroinflammation; Neurons; Type 2 diabetes; West Nile virus encephalitis

Indexed keywords

CXCL1 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; CELL ADHESION MOLECULE; CYTOKINE; LEPTIN RECEPTOR; LEPTIN RECEPTOR, MOUSE; LEUKOCYTE ANTIGEN; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FLAVIVIRUS INFECTION; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; LEUKOCYTE MIGRATION; MALE; MOUSE; NERVE CELL NECROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; VIRUS LOAD; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CELL MOTION; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; LEUKOCYTE; METABOLISM; NERVE CELL; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; WEST NILE FEVER;

ANIMALS; ANTIGENS, CD; BRAIN; CELL ADHESION MOLECULES; CELL MOVEMENT; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, LEPTIN; SPLEEN; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84899624208     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-80     Document Type: Article

References (62)

1. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001, 15:407-421. 10.1016/S0891-5520(05)70153-7, 11447703.
2. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999, 26:259-265. 10.1111/j.1574-695X.1999.tb01397.x, 10575137.
3. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997, 14:29-34. 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V, 9017350.
4. Saeed FA, Castle GE. Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections. Clin Diagn Lab Immunol 1998, 5:740-743. 95650, 9729546.
5. Katz S, Klein B, Elian I, Fishman P, Djaldetti M. Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 1983, 6:479-482. 10.2337/diacare.6.5.479, 6443809.
6. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107. 10.1038/nri2925, 21233852.
7. Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004, 123:87-92. 10.1111/j.0022-202X.2004.22711.x, 15191547.
8. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 2000, 102:185-190. 10.1161/01.CIR.102.2.185, 10889129.
9. Hill HR, Augustine NH, Rallison ML, Santos JI. Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 1983, 3:70-77. 10.1007/BF00919141, 6338028.
10. Rummel C, Inoue W, Poole S, Luheshi GN. Leptin regulates leukocyte recruitment into the brain following systemic LPS-induced inflammation. Mol Psychiatry 2010, 15:523-534. 10.1038/mp.2009.98, 19773811.
11. Andreasen AS, Pedersen-Skovsgaard T, Berg RM, Svendsen KD, Feldt-Rasmussen B, Pedersen BK, Moller K. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med 2010, 36:1548-1555. 10.1007/s00134-010-1845-1, 20229041.
12. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 2006, 57:181-194. 10.1146/annurev.med.57.121304.131418, 16409144.
13. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. J Am Med Assoc 2003, 290:511-515.
14. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, Wong S, Layton M,. West Nile Outbreak Response Working Group The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 1999, 2001(344):1807-1814. West Nile Outbreak Response Working Group.
15. Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis 2011, 11:161-164. 10.1089/vbz.2009.0086, 20687860.
16. Patnaik JL, Harmon H, Vogt RL. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 2006, 12:1129-1131. 10.3201/eid1207.051399, 3291048, 16836833.
17. Guarner J, Shieh WJ, Hunter S, Paddock CD, Morken T, Campbell GL, Marfin AA, Zaki SR. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 2004, 35:983-990. 10.1016/j.humpath.2004.04.008, 15297965.
18. Nolan MS, Podoll AS, Hause AM, Akers KM, Finkel KW, Murray KO. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS One 2012, 7:e40374. 10.1371/journal.pone.0040374, 3391259, 22792293.
19. Kumar M, Roe K, Nerurkar PV, Namekar M, Orillo B, Verma S, Nerurkar VR. Impaired virus clearance, compromised immune response and increased mortality in Type 2 diabetic mice infected with West Nile virus. PLoS One 2012, 7:e44682. 10.1371/journal.pone.0044682, 3432127, 22953001.
20. Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007, 13:1918-1920. 10.3201/eid1312.061265, 2876738, 18258047.
21. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006, 42:1234-1240. 10.1086/503038, 16586381.
22. Cook RL, Xu X, Yablonsky EJ, Sakata N, Tripp JH, Hess R, Piazza P, Rinaldo CR. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg 2010, 83:1133-1136. 10.4269/ajtmh.2010.09-0717, 2963984, 21036852.
23. Abroug F, Ouanes-Besbes L, Letaief M, Ben Romdhane F, Khairallah M, Triki H, Bouzouiaia N. 1. Mayo Clin Proc 2006, 81:12-16. 10.4065/81.1.12, 16438473.
24. Shrestha B, Gottlieb D, Diamond MS. Infection and injury of neurons by West Nile encephalitis virus. J Virol 2003, 77:13203-13213. 10.1128/JVI.77.24.13203-13213.2003, 296085, 14645577.
25. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 2005, 202:1087-1098. 10.1084/jem.20042530, 2213214, 16230476.
26. Petzold A, Groves M, Leis AA, Scaravilli F, Stokic DS. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection. Muscle Nerve 2010, 41:42-49. 10.1002/mus.21448, 19790244.
27. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 2005, 79:13350-13361. 10.1128/JVI.79.21.13350-13361.2005, 1262587, 16227257.
28. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003, 77:2578-2586. 10.1128/JVI.77.4.2578-2586.2003, 141119, 12551996.
29. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005, 79:11457-11466. 10.1128/JVI.79.17.11457-11466.2005, 1193600, 16103196.
30. Shrestha B, Diamond MS. Role of CD8+ T cells in control of West Nile virus infection. J Virol 2004, 78:8312-8321. 10.1128/JVI.78.15.8312-8321.2004, 446114, 15254203.
31. Dai J, Wang P, Bai F, Town T, Fikrig E. Icam-1 participates in the entry of West Nile virus into the central nervous system. J Virol 2008, 82:4164-4168. 10.1128/JVI.02621-07, 2292986, 18256150.
32. Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol 2008, 82:8956-8964. 10.1128/JVI.01118-08, 2546880, 18632856.
33. Verma S, Hoffmann FW, Kumar M, Huang Z, Roe K, Nguyen-Wu E, Hashimoto AS, Hoffmann PR. Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses. J Immunol 2011, 186:2127-2137. 10.4049/jimmunol.1002878, 3088479, 21220695.
34. Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M, Verma S. Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in West Nile virus encephalitis. J Virol 2013, 87:3655-3667. 10.1128/JVI.02667-12, 3624239, 23302887.
35. Verma S, Kumar M, Gurjav U, Lum S, Nerurkar VR. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 2010, 397:130-138. 10.1016/j.virol.2009.10.036, 3102050, 19922973.
36. Verma S, Lo Y, Chapagain M, Lum S, Kumar M, Gurjav U, Luo H, Nakatsuka A, Nerurkar VR. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier. Virology 2009, 385:425-433. 10.1016/j.virol.2008.11.047, 2684466, 19135695.
37. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, Verma S. West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol 2012, 93:1193-1203. 10.1099/vir.0.040899-0, 3755517, 22398316.
38. Kumar M, Verma S, Nerurkar VR. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J Neuroinflammation 2010, 7:73. 10.1186/1742-2094-7-73, 2984415, 21034511.
39. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell IL, King NJ. Ly6c + " inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 2008, 205:2319-2337. 10.1084/jem.20080421, 2556789, 18779347.
40. Lim JK, Obara CJ, Rivollier A, Pletnev AG, Kelsall BL, Murphy PM. Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol 2011, 186:471-478. 10.4049/jimmunol.1003003, 3402345, 21131425.
41. Shen J, T-To SS, Schrieber L, King NJ. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J Virol 1997, 71:9323-9332. 230235, 9371591.
42. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Deffrasnes C, Ashhurst TM, Radford J, Hofer M, Thomas S, Campbell IL, King NJ. Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J Neuroinflammation 2012, 9:246. 10.1186/1742-2094-9-246, 3532418, 23111065.
43. Diamond MS, Mehlhop E, Oliphant T, Samuel MA. The host immunologic response to West Nile encephalitis virus. Front Biosci 2009, 14:3024-3034.
44. Samuel MA, Morrey JD, Diamond MS. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol 2007, 81:2614-2623. 10.1128/JVI.02311-06, 1866006, 17192305.
45. Bai F, Kong KF, Dai J, Qian F, Zhang L, Brown CR, Fikrig E, Montgomery RR. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis 2010, 202:1804-1812. 10.1086/657416, 3053000,3053000, 21050124.
46. Shrestha B, Diamond MS. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol 2007, 81:11749-11757. 10.1128/JVI.01136-07, 2168805, 17804505.
47. Shrestha B, Samuel MA, Diamond MS. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 2006, 80:119-129. 10.1128/JVI.80.1.119-129.2006, 1317548, 16352536.
48. Sannomiya P, Oliveira MA, Fortes ZB. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study. Br J Pharmacol 1997, 122:894-898. 10.1038/sj.bjp.0701448, 1565005, 9384505.
49. Spiller F, Carlos D, Souto FO, de Freitas A, Soares FS, Vieira SM, Paula FJ, Alves-Filho JC, Cunha FQ. Alpha1-acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice. Diabetes 2012, 61:1584-1591. 10.2337/db11-0825, 3357278, 22415874.
50. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 2009, 77:456-463. 10.1128/IAI.00503-08, 2612264, 18955471.
51. Kelley TW, Prayson RA, Ruiz AI, Isada CM, Gordon SM. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am J Clin Pathol 2003, 119:749-753. 10.1309/PU4R76JJMG1F81RP, 12760295.
52. Verma S, Kumar M, Nerurkar VR. Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes. J Gen Virol 2011, 92:507-515. 10.1099/vir.0.026716-0, 3081232, 21106803.
53. van Marle G, Antony J, Ostermann H, Dunham C, Hunt T, Halliday W, Maingat F, Urbanowski MD, Hobman T, Peeling J, Power C. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence. J Virol 2007, 81:10933-10949. 10.1128/JVI.02422-06, 2045515, 17670819.
54. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR. Differential responses of human brain cells to West Nile virus infection. J Neurovirol 2005, 11:512-524. 10.1080/13550280500384982, 16338745.
55. Wong D, Prameya R, Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J Neuropathol Exp Neurol 1999, 58:138-152. 10.1097/00005072-199902000-00004, 10029097.
56. Mestre L, Inigo PM, Mecha M, Correa FG, Hernangomez-Herrero M, Loria F, Docagne F, Borrell J, Guaza C. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB (1) receptors. J Neuroinflammation 2011, 8:102. 10.1186/1742-2094-8-102, 3173342, 21851608.
57. Mestre L, Docagne F, Correa F, Loria F, Hernangomez M, Borrell J, Guaza C. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci 2009, 40:258-266. 10.1016/j.mcn.2008.10.015, 19059482.
58. Inoue A, Koh CS, Yamazaki M, Ichikawa M, Isobe M, Ishihara Y, Yagita H, Kim BS. Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int Immunol 1997, 9:1837-1847. 10.1093/intimm/9.12.1837, 9466311.
59. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373. 10.1038/nm1140, 15558055.
60. Garcia-Tapia D, Hassett DE, Mitchell WJ, Johnson GC, Kleiboeker SB. West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol 2007, 13:130-138. 10.1080/13550280601187185, 17505981.
61. Park S, Rich J, Hanses F, Lee JC. Defects in innate immunity predispose C57BL/6 J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun 2009, 77:1008-1014. 10.1128/IAI.00976-08, 2643648, 19103772.
62. Nagajyothi F, Zhao D, Machado FS, Weiss LM, Schwartz GJ, Desruisseaux MS, Zhao Y, Factor SM, Huang H, Albanese C, Teixeira MM, Scherer PE, Chua SC, Tanowitz HB. Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis 2010, 202:1104-1113. 10.1086/656189, 2932826, 20726767.